HAYLEY ZIMMERMAN: Open Payments
NPI 1255836011 · FORT WORTH, TX. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,043 in 43 payments from 25 companies in 2025. Trend: 2023 $1,036 · 2024 $1,436 · 2025 $1,043
Food & beverage: $1,043
| Company | Payments | Amount |
|---|---|---|
| Celgene Corporation | 4 | $110 |
| AstraZeneca Pharmaceuticals LP | 4 | $96 |
| Stemline Therapeutics Inc. | 3 | $78 |
| ARRAY BIOPHARMA INC | 3 | $77 |
| Daiichi Sankyo Inc. | 3 | $71 |
| Genmab U.S., Inc. | 2 | $61 |
| Janssen Scientific Affairs, LLC | 2 | $52 |
| SOBI, INC | 2 | $50 |
| Lilly USA, LLC | 2 | $45 |
| SERVIER PHARMACEUTICALS LLC | 2 | $44 |
Products named: REBLOZYL, Enhertu, Epkinly, XALKORI, Doptelet, CALQUENCE, Orserdu, VERZENIO.
Industry payments across TX — which companies pay providers there.
